Lyra Therapeutics Inc
NASDAQ:LYRA
Lyra Therapeutics Inc
NASDAQ:LYRA
Price:
0.4902
USD
Market Closed
Market Cap:
$867.7k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lyra Therapeutics Inc
NASDAQ:LYRA
|
US |
|
V
|
VAA Vista Alegre Atlantis SGPS SA
ELI:VAF
|
PT |
|
Arteris Inc
NASDAQ:AIP
|
US |
|
Civeo Corp
NYSE:CVEO
|
US |
|
D
|
Datalex PLC
ISEQ:DLE
|
IE |
|
P
|
Polyplex Thailand PCL
SET:PTL
|
TH |
|
B
|
Big Technologies PLC
LSE:BIG
|
UK |
|
Rxsight Inc
NASDAQ:RXST
|
US |
|
Telus Corp
TSX:T
|
CA |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LYRA's stock price target?
Not Available
LYRA doesn't have any price targets made by Wall Street professionals.
What is Lyra Therapeutics Inc's Revenue forecast?
Projected CAGR
122%
122%
The
compound annual growth rate
of Lyra Therapeutics Inc's revenue for the next 4 years is
122%.
